Pharma Mar SA

(PHMMF)

By |

Profile

Pharma Mar SA develops and commercializes YONDELIS in Europe and has three clinical-stage programs under development, in addition to trabectedin, for several types of solid and hematological cancers, PM1183, plitidepsin, and PM60184.

Contact Information

Website: www.pharmamar.com
Main Phone: +34 918466000
Address: Avda. De los Reyes, 1
Address 2: Pol. Ind. La Mina
City / Town: Madrid
Country: ESP
Postal Code: 28770

Issuer Information

Exchange: OTO
Employees: 700
$ 2.67 ($ 0.03) (-1.22%)
Last Price 2.67 Change $ -0.03 Change % -1.22 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 2.62 High 2.75 Low 2.62 Prev Close 2.70
Last Trade Volume 5,070 52 Wk Hi 3.65 52 Wk Low 2.13
Market Cap 590.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 221,309,097.00 EPS (TTM) -0.09 PE Ratio N/A Exchange OTCPK